An Overlooked Issue: Sexual Dysfunction in Menopause Menopause is a time of profound physical, hormonal, and emotional changes in a woman’s life. One of the most common—but often neglected—consequences is sexual dysfunction, which can include reduced desire, vaginal dryness, pain during intercourse, difficulty with arousal, and trouble reaching orgasm. According to some estimates, up to…
Medical device with hyaluronic acid and natural actives to relieve dryness, itching, irritation, and intimate infections We are proud to announce that our vaginal ovule, a Class IIa medical device, has been officially registered with the Cabinet of Ministers of Ukraine. This milestone confirms the safety and effectiveness of our formula, developed to meet the…
Medical device based on 3% Boric Acid for the treatment of vaginal infections and dryness: results after 4 weeks of treatment Vaginal infections, particularly those caused by Candida albicans, represent one of the main causes of intimate discomfort in women, with recurrent episodes that significantly affect daily well-being and quality of life. To meet this…
MDD Certified Vaginal Tablets for Intimate Health The Medical Device Regulation (MDR), in effect since May 2017 and fully applicable from May 2021, regulates medical devices in Europe. Thanks to deadline extensions, devices compliant with the MDD Directive can continue to be marketed until December 31, 2027, for Class III and implantable Class IIb devices,…
Vaginal Suppository with Boric Acid for Intimate Well-Being We are pleased to announce the recent registration of our vaginal suppository with the Ministry of Health and Prevention of the United Arab Emirates. Formulated as a medical device, it provides restoration of protection, hydration, and pH balance. Its triple antibacterial, antifungal, and antimicrobial action helps prevent…
MDD Certification for Our Vaginal Ovules: A New Milestone for Intimate Health The MDR Regulation, in force since May 2017 and applicable from May 2021, governs European medical devices. Deadline extensions allow medical devices compliant with the Medical Device Directive (MDD) to be marketed until December 31, 2027, for Class III and implantable Class IIb…
Vaginal Gel: Registered Medical Device in UK for Women’s Intimate Well-Being We are pleased to announce the official registration with the relevant authorities in the UK of a Class II medical device, compliant with MDD regulations. This is a vaginal gel with a pH of 4.5, packaged in practical 5 ml tubes (6 tubes per…
Extension of the MDD Certificate for Our Medical Devices Supporting Women’s Wellness at Every Stage of Life The MDR Regulation, in effect since May 2017 and applicable from May 2021, governs medical devices in Europe. Deadline extensions allow the marketing of devices compliant with the Medical Device Directive (MDD) until December 31, 2027, for class…
Effective vaginal relief: medical device registered in Vietnam for women’s well-being GFI proudly announces that we have successfully registered a Class IIa medical device in Vietnam, formulated with natural ingredients. This device is a vaginal ovule composed of hyaluronic acid, lactic acid, Centella Asiatica, calendula, chamomile, and tea tree oil. Indicated to addressing a wide…
Clinical study: Vaginal ovules containing hyaluronic acid, polycarbophil and lactic acid for vulvovaginal symptoms such as burning, dryness, irritation, dysuria and dyspareunia Gruppo FarmaImpresa is required, for regulatory reasons, to regularly follow a postmarketing surveillance system called postmarketing clinical follow-up (PMCF). The PMCF is a continuous and proactive process that aims to continuously evaluate the…